| Aug 14 |
MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update
|
| Aug 13 |
MediWound Q2 2024 Earnings Preview
|
| Aug 2 |
MediWound to Report Second Quarter 2024 Financial Results
|
| Jul 31 |
Can MediWound Climb 57.49% to Reach the Level Wall Street Analysts Expect?
|
| Jul 31 |
Can MediWound (MDWD) Climb 57.49% to Reach the Level Wall Street Analysts Expect?
|
| Jul 30 |
MediWound reinforces wound therapy EscharEx data ahead of Phase III trial
|
| Jul 29 |
MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers
|
| Jul 15 |
MediWound receives $15M investment from Molnlycke Health Care
|
| Jul 15 |
MediWound announces $25M private placement financing
|
| Jul 15 |
Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd
|
